EP3684382A4 - Amniongewebepräparate und verfahren zur verwendung - Google Patents

Amniongewebepräparate und verfahren zur verwendung Download PDF

Info

Publication number
EP3684382A4
EP3684382A4 EP18859483.2A EP18859483A EP3684382A4 EP 3684382 A4 EP3684382 A4 EP 3684382A4 EP 18859483 A EP18859483 A EP 18859483A EP 3684382 A4 EP3684382 A4 EP 3684382A4
Authority
EP
European Patent Office
Prior art keywords
methods
tissue preparation
amniotic tissue
amniotic
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP18859483.2A
Other languages
English (en)
French (fr)
Other versions
EP3684382A1 (de
Inventor
Gary M. Petrucci
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US15/708,413 external-priority patent/US10251917B1/en
Priority claimed from US15/708,425 external-priority patent/US20190083547A1/en
Application filed by Individual filed Critical Individual
Publication of EP3684382A1 publication Critical patent/EP3684382A1/de
Publication of EP3684382A4 publication Critical patent/EP3684382A4/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP18859483.2A 2017-09-19 2018-09-19 Amniongewebepräparate und verfahren zur verwendung Pending EP3684382A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15/708,413 US10251917B1 (en) 2017-09-19 2017-09-19 Methods and materials for treating tumors
US15/708,425 US20190083547A1 (en) 2017-09-19 2017-09-19 Transdermal delivery of amnion tissue preparations
PCT/US2018/051651 WO2019060355A1 (en) 2017-09-19 2018-09-19 PREPARATION OF AMNIOTIC FABRIC AND METHODS OF USE

Publications (2)

Publication Number Publication Date
EP3684382A1 EP3684382A1 (de) 2020-07-29
EP3684382A4 true EP3684382A4 (de) 2021-06-09

Family

ID=65809869

Family Applications (1)

Application Number Title Priority Date Filing Date
EP18859483.2A Pending EP3684382A4 (de) 2017-09-19 2018-09-19 Amniongewebepräparate und verfahren zur verwendung

Country Status (3)

Country Link
EP (1) EP3684382A4 (de)
CA (1) CA3076485A1 (de)
WO (1) WO2019060355A1 (de)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5612028A (en) * 1988-02-17 1997-03-18 Genethics Limited Method of regenerating or replacing cartilage tissue using amniotic cells
US20100124569A1 (en) * 2008-11-19 2010-05-20 Abbot Stewart Amnion derived adherent cells
US20150335686A1 (en) * 2014-05-21 2015-11-26 Mimedx Group, Inc. Micronized wharton's jelly
US20160199417A1 (en) * 2014-06-15 2016-07-14 Amnio Technology Llc Method of treatment utilizing an acellular amnion derived therapeutic composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012092480A1 (en) * 2010-12-30 2012-07-05 Anthirogenesis Corporation Compositions comprising amnion derived adherent cells and platelet-rich plasma
US8961617B2 (en) * 2012-03-08 2015-02-24 Liventa Bioscience, Inc. Amnion and chorion constructs and uses thereof in abdominal surgery
US10617785B2 (en) * 2014-08-28 2020-04-14 Mimedx Group, Inc. Collagen reinforced tissue grafts
US9238090B1 (en) * 2014-12-24 2016-01-19 Fettech, Llc Tissue-based compositions

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5612028A (en) * 1988-02-17 1997-03-18 Genethics Limited Method of regenerating or replacing cartilage tissue using amniotic cells
US20100124569A1 (en) * 2008-11-19 2010-05-20 Abbot Stewart Amnion derived adherent cells
US20150335686A1 (en) * 2014-05-21 2015-11-26 Mimedx Group, Inc. Micronized wharton's jelly
US20160199417A1 (en) * 2014-06-15 2016-07-14 Amnio Technology Llc Method of treatment utilizing an acellular amnion derived therapeutic composition

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
SARALIDZE ET AL: "New acrylic microspheres for arterial embolization: Combining radiopacity for precise localization with immobilized thrombin to trigger local blood coagulation", BIOMATERIALS, ELSEVIER, AMSTERDAM, NL, vol. 28, no. 15, 13 March 2007 (2007-03-13), pages 2457 - 2464, XP005919506, ISSN: 0142-9612, DOI: 10.1016/J.BIOMATERIALS.2006.12.031 *
See also references of WO2019060355A1 *

Also Published As

Publication number Publication date
CA3076485A1 (en) 2019-03-28
EP3684382A1 (de) 2020-07-29
WO2019060355A1 (en) 2019-03-28

Similar Documents

Publication Publication Date Title
EP3694529A4 (de) Trispezifische proteine und verfahren zur verwendung
EP3411012A4 (de) Zusammensetzungen und verfahren für invasive und nicht-invasive prozedurale hautpflege
EP3684361A4 (de) Substituierte inhibitoren von menin-mll und verfahren zur verwendung
EP3423564A4 (de) Aus pluripotenten stammzellen abgeleitete mikroglia und verfahren zur herstellung und verwendung davon
EP3727394A4 (de) Digitalisierte menschliche organoide und verfahren zu deren verwendung
EP3402549A4 (de) Mikronadelzusammensetzungen und verfahren zur verwendung davon
EP3843720A4 (de) Zusammensetzungen aus cxcr4-inhibitoren und verfahren zur herstellung und verwendung
MA42243A (fr) Anticorps de facteur xi et méthodes d'utilisation
EP3322359A4 (de) Chirurgisches instrument und verfahren zur verwendung
EP3397149A4 (de) Gewebekartierung und behandlung
EP2884844A4 (de) Mikronisierte plazentagewebezusammensetzungen sowie verfahren zu ihrer herstellung und verwendung
EP3352771A4 (de) Nabelschnurgewebezusammensetzungen und verfahren zur verwendung
EP3400028A4 (de) Hautverbessernde chirurgische nahtmaterialien
ZA201801300B (en) Composition and medical device comprising acetylsalicylic acid for the treatment of human papilloma virus skin infections
EP3713583A4 (de) Verfahren und zusammensetzungen zur behandlung der haut
EP3829307A4 (de) Wismuth-thiolzusammensetzungen und verwendungsverfahren
MX2018013409A (es) Métodos y dispositivos para la preparación de agentes de contraste de ultrasonido.
MA44862A (fr) Formulations de fulvestrant et méthodes d'utilisation de celles-ci
EP3582768A4 (de) Formulierungen von cannabinoiden zur behandlung von dermatitis und entzündlichen hauterkrankungen
EP3407826A4 (de) Feste, hybride dentalbefestigungsanordnung und verfahren zur verwendung
EP3773539A4 (de) Zusammensetzungen zur hautbehandlung
EP3856147A4 (de) Verfahren und probiotische zusammensetzungen zur behandlung von knochenerkrankungen
EP3506895A4 (de) Magnesiumbiotinatzusammensetzungen und verfahren zur verwendung
EP3840769A4 (de) Cyclosporinzusammensetzungen und verfahren zur verwendung
EP3576601A4 (de) Vorrichtungen und verfahren zur abbildung von herzgewebe

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20200325

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20210507

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 35/12 20150101AFI20210430BHEP

Ipc: A61K 35/48 20150101ALI20210430BHEP

Ipc: A61K 35/50 20150101ALI20210430BHEP

Ipc: A61K 9/00 20060101ALI20210430BHEP

Ipc: A61K 9/16 20060101ALI20210430BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20240513